Consolidated Investment Group LLC Has $5.23 Million Stock Holdings in UnitedHealth Group Incorporated $UNH

Consolidated Investment Group LLC grew its position in UnitedHealth Group Incorporated (NYSE:UNH) by 26.4% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 16,750 shares of the healthcare conglomerate’s stock after purchasing an additional 3,500 shares during the period. Consolidated Investment Group LLC’s holdings in UnitedHealth Group were worth $5,225,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Retirement Planning Group LLC raised its holdings in shares of UnitedHealth Group by 5.1% during the first quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate’s stock worth $225,000 after acquiring an additional 21 shares during the period. Net Worth Advisory Group raised its holdings in shares of UnitedHealth Group by 0.6% during the first quarter. Net Worth Advisory Group now owns 3,642 shares of the healthcare conglomerate’s stock worth $1,907,000 after acquiring an additional 21 shares during the period. Bensler LLC grew its position in UnitedHealth Group by 0.3% in the first quarter. Bensler LLC now owns 6,945 shares of the healthcare conglomerate’s stock valued at $3,637,000 after purchasing an additional 22 shares in the last quarter. Lakeridge Wealth Management LLC grew its position in UnitedHealth Group by 5.8% in the first quarter. Lakeridge Wealth Management LLC now owns 420 shares of the healthcare conglomerate’s stock valued at $220,000 after purchasing an additional 23 shares in the last quarter. Finally, Broadway Wealth Solutions Inc. grew its position in UnitedHealth Group by 2.1% in the first quarter. Broadway Wealth Solutions Inc. now owns 1,151 shares of the healthcare conglomerate’s stock valued at $603,000 after purchasing an additional 24 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

UNH has been the subject of a number of analyst reports. Morgan Stanley raised their target price on shares of UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a research report on Friday, September 12th. Weiss Ratings reissued a “sell (d+)” rating on shares of UnitedHealth Group in a research report on Saturday, September 27th. Wells Fargo & Company decreased their price objective on shares of UnitedHealth Group from $306.00 to $267.00 and set an “overweight” rating for the company in a research report on Monday, August 4th. Baird R W downgraded shares of UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research report on Thursday, July 31st. Finally, Royal Bank Of Canada decreased their price objective on shares of UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating for the company in a research report on Wednesday, July 30th. Sixteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and four have issued a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $358.95.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock opened at $360.17 on Friday. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The company has a 50-day simple moving average of $307.84 and a two-hundred day simple moving average of $355.58. The stock has a market capitalization of $326.20 billion, a price-to-earnings ratio of 15.61, a price-to-earnings-growth ratio of 2.30 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same quarter last year, the firm earned $6.80 EPS. UnitedHealth Group’s revenue for the quarter was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were given a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. UnitedHealth Group’s payout ratio is presently 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.